Rivian is betting on its R2 EV to turn the automaker into a household name like Tesla
The R2 SUV is meant to transform Rivian from a niche EV manufacturer that sells luxury vehicles into a more mainstream brand like U.S. EV leader Tesla.
Oil prices fall nearly 4% after U.S. Energy Secretary says Hormuz ship traffic is increasing
President Donald Trump has repeatedly said a deal with Tehran to reopen Hormuz is close, but such an agreement still has not materialized.
The ‘SaaSpocalypse’ is over, says private equity giant Thoma Bravo. Here’s why it sees an AI boom for software
Thoma Bravo founder Orlando Bravo says AI offers an “enormous tailwind” for software companies.
Stocks are recovering from a sell-off — but even bullish investors warn of a bumpy ride ahead
Stocks edged higher on Tuesday, marking a tentative recovery from a bout of volatility led by an aggressive sell-off of global technology shares.
Bitcoin’s brutal sell-off sparks a flurry of trading in related stocks, including one big bullish bet
The year has been a rocky one for the flagship cryptocurrency, but traders aren’t backing away from the space.
Gold could slump another 20% by September, says Citi — here’s why
Since the outbreak of the U.S.-Iran war on Feb. 28, gold’s reputation as a “safe haven” asset in times of turmoil has come under pressure.
India’s growth story faces its toughest test yet in Modi’s third term
Prime Minister Narendra Modi faces his biggest test as India’s appeal as the world’s fastest-growing economy dims for global investors.
Indonesia raises rates in surprise move as rupiah lingers near record lows
In a statement, the central bank said this was also a “pre-emptive measure” to maintain inflation within the government’s target range of 1.5% to 3.5%.
Trump repeats claims that Iran deal is only ‘days’ away, despite recent strikes
Speaking to reporters after attending the NBA Finals in New York, Trump said the two parties are in the final stages of a “very, very good deal”.
The space race is coming for pharma: Why drug development is heading to lower Earth orbit
Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.
